Rituximab and intravenous immune globulin for desensitization during renal transplantation. [electronic resource]
Producer: 20080722Description: 242-51 p. digitalISSN:- 1533-4406
- Adult
- Antibodies -- blood
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD19 -- blood
- Antigens, CD20 -- immunology
- Creatinine -- blood
- Desensitization, Immunologic -- methods
- Drug Therapy, Combination
- Female
- Graft Rejection -- epidemiology
- HLA Antigens -- immunology
- Humans
- Immunoglobulins, Intravenous -- adverse effects
- Immunologic Factors -- adverse effects
- Immunosuppression Therapy -- methods
- Kidney Transplantation -- immunology
- Male
- Middle Aged
- Rituximab
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.